{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "20970412", "DateCompleted": {"Year": "2011", "Month": "08", "Day": "01"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2010", "Month": "10", "Day": "21"}], "Language": ["eng"], "ELocationID": ["10.1016/j.cbi.2010.10.007"], "Journal": {"ISSN": "1872-7786", "JournalIssue": {"Volume": "192", "Issue": "1-2", "PubDate": {"Year": "2011", "Month": "Jun", "Day": "30"}}, "Title": "Chemico-biological interactions", "ISOAbbreviation": "Chem Biol Interact"}, "ArticleTitle": "Biological reactive intermediates (BRIs) formed from botanical dietary supplements.", "Pagination": {"StartPage": "72", "EndPage": "80", "MedlinePgn": "72-80"}, "Abstract": {"AbstractText": ["The use of botanical dietary supplements is increasingly popular, due to their natural origin and the perceived assumption that they are safer than prescription drugs. While most botanical dietary supplements can be considered safe, a few contain compounds, which can be converted to biological reactive intermediates (BRIs) causing toxicity. For example, sassafras oil contains safrole, which can be converted to a reactive carbocation forming genotoxic DNA adducts. Alternatively, some botanical dietary supplements contain stable BRIs such as simple Michael acceptors that react with chemosensor proteins such as Keap1 resulting in induction of protective detoxification enzymes. Examples include curcumin from turmeric, xanthohumol from hops, and Z-ligustilide from dang gui. Quinones (sassafras, kava, black cohosh), quinone methides (sassafras), and epoxides (pennyroyal oil) represent BRIs of intermediate reactivity, which could generate both genotoxic and/or chemopreventive effects. The biological targets of BRIs formed from botanical dietary supplements and their resulting toxic and/or chemopreventive effects are closely linked to the reactivity of BRIs as well as dose and time of exposure."], "CopyrightInformation": "Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved."}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy and UIC/NIH Center for Botanical and Dietary Supplements Research, University of Illinois at Chicago, College of Pharmacy, 833 S. Wood Street, M/C 781, Chicago, IL 60612-7231, USA."}], "Identifier": [], "LastName": "Dietz", "ForeName": "Birgit M", "Initials": "BM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bolton", "ForeName": "Judy L", "Initials": "JL"}], "GrantList": [{"GrantID": "P50 AT000155", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}, {"GrantID": "R21 CA135237", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "CA135237", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "P50 AT00155", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Review"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "Chem Biol Interact", "NlmUniqueID": "0227276", "ISSNLinking": "0009-2797"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Xenobiotics"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Biological Products"}, {"QualifierName": [], "DescriptorName": "Dietary Supplements"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants"}, {"QualifierName": ["isolation & purification"], "DescriptorName": "Xenobiotics"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Gershwin ME, Borchers AT, Keen CL, Hendler S, Hagie F, Greenwood MR. Public safety and dietary supplementation. Ann. N. Y. Acad. Sci. 2010;1190(1):104\u2013117.", "ArticleIdList": ["20388141"]}, {"Citation": "Bent S, Ko R. Commonly used herbal medicines in the United States: a review. Am. J. Med. 2004;116(7):478\u2013485. see comment.", "ArticleIdList": ["15047038"]}, {"Citation": "Sadovsky R, Collins N, Tighe AP, Brunton SA, Safeer R. Patient use of dietary supplements: a clinician\u2019s perspective. Curr. Med. Res. Opin. 2008;24(4):1209\u20131216.", "ArticleIdList": ["18348745"]}, {"Citation": "Rietjens IM, Martena MJ, Boersma MG, Spiegelenberg W, Alink GM. Molecular mechanisms of toxicity of important food-borne phytotoxins. Mol. Nutr. Food Res. 2005;49(2):131\u2013158.", "ArticleIdList": ["15635687"]}, {"Citation": "Furbee RB, Barlotta KS, Allen MK, Holstege CP. Hepatotoxicity associated with herbal products. Clin. Lab Med. 2006;26(1):227\u2013241.", "ArticleIdList": ["16567233"]}, {"Citation": "Kennedy DA, Seely D. Clinically based evidence of drug-herb interactions: a systematic review. Expert Opin. Drug Saf. 2010;9(1):79\u2013124.", "ArticleIdList": ["20021292"]}, {"Citation": "Mayr H, Ofial AR. The reactivity-selectivity principle: an imperishable myth in organic chemistry. Angew. Chem. Int. Ed. Engl. 2006;45(12):1844\u20131854.", "ArticleIdList": ["16470749"]}, {"Citation": "Dinkova-Kostova AT, Massiah MA, Bozak RE, Hicks RJ, Talalay P. From the Cover: Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc. Natl. Acad. Sci. USA. 2001;98(6):3404\u20133409.", "ArticleIdList": ["PMC30666", "11248091"]}, {"Citation": "Johnson BM, Bolton JL, van Breemen RB. Screening botanical extracts for quinoid metabolites. Chem. Res. Toxicol. 2001;14(11):1546\u20131551.", "ArticleIdList": ["11712913"]}, {"Citation": "Kamdem DP, Gage DA. Chemical composition of essential oil from the root bark of Sassafras albidum. Planta Med. 1995;61(6):574\u2013575.", "ArticleIdList": ["8824955"]}, {"Citation": "Fennell TR, Miller JA, Miller EC. Characterization of the biliary and urinary glutathione and N-acetylcysteine metabolites of the hepatic carcinogen 1\u2032-hydroxysafrole and its 1\u2032-oxo metabolite in rats and mice. Cancer Res. 1984;44(8):3231\u20133240.", "ArticleIdList": ["6744260"]}, {"Citation": "Heikes DL. SFE with GC and MS determination of safrole and related allylbenzenes in sassafras teas. J. Chromatogr. Sci. 1994;32(7):253\u2013258.", "ArticleIdList": ["8063885"]}, {"Citation": "Food and Drug Administration . In: Everything Added to Food in the United States (EAFUS): Oil of sassafras, safrole free -\u00a7 172.580 Safrole-free extract of sassafras. U.D.o.h.h.a.h. services, editor. 2010."}, {"Citation": "Bolton JL, Acay NM, Vukomanovic V. Evidence that 4-allyl-o-quinones spontaneously rearrange to their more electrophilic quinone methides: potential bioactivation mechanism for the hepatocarcinogen safrole. Chem. Res. Toxicol. 1994;7(3):443, 450.", "ArticleIdList": ["8075378"]}, {"Citation": "Miller EC, Swanson AB, Phillips DH, Fletcher TL, Liem A, Miller JA. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res. 1983;43(3):1124\u20131134.", "ArticleIdList": ["6825084"]}, {"Citation": "Rietjens IM, Boersma MG, van der Woude H, Jeurissen SM, Schutte ME, Alink GM. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk. Mutat. Res. 2005;574(1-2):124\u2013138.", "ArticleIdList": ["15914212"]}, {"Citation": "Miller EC, Miller JA, Boberg EW, Delclos KB, Lai CC, Fennell TR, Wiseman RW, Liem A. Sulfuric acid esters as ultimate electrophilic and carcinogenic metabolites of some alkenylbenzenes and aromatic amines in mouse liver. Carcinog. Compr. Surv. 1985;10:93\u2013107.", "ArticleIdList": ["3904999"]}, {"Citation": "Jeng JH, Wang YJ, Chang WH, Wu HL, Li CH, Uang BJ, Kang JJ, Lee JJ, Hahn LJ, Lin BR, Chang MC. Reactive oxygen species are crucial for hydroxychavicol toxicity toward KB epithelial cells. Cell. Mol. Life Sci. 2004;61(1):83\u201396.", "ArticleIdList": ["PMC11138776", "14704856"]}, {"Citation": "Nakagawa Y, Suzuki T, Nakajima K, Ishii H, Ogata A. Biotransformation and cytotoxic effects of hydroxychavicol, an intermediate of safrole metabolism, in isolated rat hepatocytes. Chem. Biol. Interact. 2009;180(1):89\u201397.", "ArticleIdList": ["19428348"]}, {"Citation": "Luo G, Guenthner TM. Covalent binding to DNA in vitro of 2\u2032,3\u2032-oxides derived from allylbenzene analogs.[erratum appears in Drug Metab Dispos 1997 Jan;25(1):131] Drug Metab. Dispos. 1996;24(9):1020\u20131027.", "ArticleIdList": ["8886614"]}, {"Citation": "Gupta KP, van Golen KL, Putman KL, Randerath K. Formation and persistence of safrole-DNA adducts over a 10,000-fold dose range in mouse liver. Carcinogenesis. 1993;14(8):1517\u20131521.", "ArticleIdList": ["8102595"]}, {"Citation": "Randerath K, Putman KL, Randerath E. Flavor constituents in cola drinks induce hepatic DNA adducts in adult and fetal mice. Biochem. Biophys. Res. Commun. 1993;192(1):61\u201368.", "ArticleIdList": ["8476434"]}, {"Citation": "Daimon H, Sawada S, Asakura S, Sagami F. In vivo genotoxicity and DNA adduct levels in the liver of rats treated with safrole. Carcinogenesis. 1998;19(1):141\u2013146.", "ArticleIdList": ["9472705"]}, {"Citation": "Daimon H, Sawada S, Asakura S, Sagami F. Analysis of cytogenetic effects and DNA adduct formation induced by safrole in Chinese hamster lung cells. Teratog., Carcinog. Mutagen. 1997;17(1):7\u201318.", "ArticleIdList": ["9249926"]}, {"Citation": "Johnson WW. Many drugs and phytochemicals can be activated to biological reactive intermediates. Curr. Drug Metab. 2008;9(4):344\u2013351.", "ArticleIdList": ["18473753"]}, {"Citation": "Chung YT, Hsieh LL, Chen IH, Liao CT, Liou SH, Chi CW, Ueng YF, Liu TY. Sulfotransferase 1A1 haplotypes associated with oral squamous cell carcinoma susceptibility in male Taiwanese. Carcinogenesis. 2009;30(2):286\u2013294.", "ArticleIdList": ["19126640"]}, {"Citation": "Azuine MA, Amonkar AJ, Bhide SV. Chemopreventive efficacy of betel leaf extract and its constituents on 7,12-dimethylbenz(a)anthracene induced carcinogenesis and their effect on drug detoxification system in mouse skin. Indian J. Exp. Biol. 1991;29(4):346\u2013351.", "ArticleIdList": ["1908438"]}, {"Citation": "Chan TY. Potential risks associated with the use of herbal anti-obesity products. Drug Saf. 2009;32(6):453\u2013456.", "ArticleIdList": ["19459713"]}, {"Citation": "Arlt VM, Stiborova M, Schmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis. 2002;17(4):265\u2013277.", "ArticleIdList": ["12110620"]}, {"Citation": "Kessler DA. Cancer and herbs. N. Engl. J. Med. 2000;342(23):1742\u20131743. [see comment][comment]", "ArticleIdList": ["10841878"]}, {"Citation": "Stiborova M, Frei E, Hodek P, Wiessler M, Schmeiser HH. Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer. Int. J. Cancer. 2005;113(2):189\u2013197.", "ArticleIdList": ["15386410"]}, {"Citation": "Kessler DA. Cancer and herbs. N. Engl. J. Med. 2000;342(23):1742\u20131743.", "ArticleIdList": ["10841878"]}, {"Citation": "Greensfelder L. Alternative medicine. Herbal product linked to cancer. Science. 2000;288(5473):1946.", "ArticleIdList": ["10877707"]}, {"Citation": "FDA . Letter to Health Professionals Regarding Safety Concerns Related to the Use of Botanical Products Containing Aristolochic Acid. Apr 4th, 2001."}, {"Citation": "Stiborova M, Hajek M, Frei E, Schmeiser HH. Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH: cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy. Gen. Physiol. Biophys. 2001;20(4):375\u2013392.", "ArticleIdList": ["11989648"]}, {"Citation": "Stiborova M, Frei E, Wiessler M, Schmeiser HH. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2. Chem. Res. Toxicol. 2001;14(8):1128\u20131137.", "ArticleIdList": ["11511187"]}, {"Citation": "Stiborova M, Frei E, Sopko B, Wiessler M, Schmeiser HH. Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy. Carcinogenesis. 2002;23(4):617\u2013625.", "ArticleIdList": ["11960915"]}, {"Citation": "Arlt VM, Glatt H, Muckel E, Pabel U, Sorg BL, Seidel A, Frank H, Schmeiser HH, Phillips DH. Activation of 3-nitrobenzanthrone and its metabolites by human acetyltransferases, sulfotransferases and cytochrome P450 expressed in Chinese hamster V79 cells. Int. J. Cancer. 2003;105(5):583\u2013592.", "ArticleIdList": ["12740904"]}, {"Citation": "Pfau W, Schmeiser HH, Wiessler M. Aristolochic acid binds covalently to the exocyclic amino group of purine nucleotides in DNA. Carcinogenesis. 1990;11(2):313\u2013319.", "ArticleIdList": ["2302759"]}, {"Citation": "Stiborova M, Frei E, Breuer A, Wiessler M, Schmeiser HH. Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase -- (32)P-postlabeling analysis of DNA adduct formation. Mutat. Res. 2001;493(1-2):149\u2013160.", "ArticleIdList": ["11516724"]}, {"Citation": "Schmeiser HH, Janssen JW, Lyons J, Scherf HR, Pfau W, Buchmann A, Bartram CR, Wiessler M. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues. Cancer Res. 1990;50(17):5464\u20135469.", "ArticleIdList": ["2201437"]}, {"Citation": "IARC . Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. Vol. 2002. IARC; Lyon: 2002.", "ArticleIdList": ["PMC4781602", "12687954"]}, {"Citation": "Food and Drug Administration Dietary Supplements: Aristolochic Acid - FDA Concerned About Botanical Products, Including Dietary Supplements. Containing Aristolochic Acid. 2001"}, {"Citation": "Gunby P. Plant known for centuries still causes problems today. JAMA. 1979;241(21):2246\u20132247.", "ArticleIdList": ["439284"]}, {"Citation": "Anderson IB, Mullen WH, Meeker JE, Khojasteh Bakht SC, Oishi S, Nelson SD, Blanc PD. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann. Intern. Med. 1996;124(8):726\u2013734.", "ArticleIdList": ["8633832"]}, {"Citation": "Furbee RB, Barlotta KS, Allen MK, Holstege CP. Hepatotoxicity associated with herbal products. Clin. Lab. Med. 2006;26(1):227\u2013241. x.", "ArticleIdList": ["16567233"]}, {"Citation": "Chen LJ, Lebetkin EH, Burka LT. Metabolism of (R)-(+)-menthofuran in Fischer-344 rats: identification of sulfonic acid metabolites. Drug Metab. Dispos. 2003;31(10):1208\u20131213.", "ArticleIdList": ["12975329"]}, {"Citation": "Chen LJ, Lebetkin EH, Burka LT. Metabolism of (R)-(+)-pulegone in F344 rats. Drug Metab. Dispos. 2001;29(12):1567\u20131577.", "ArticleIdList": ["11717176"]}, {"Citation": "Bakerink JA, Gospe SM, Jr., Dimand RJ, Eldridge MW. Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants. Pediatrics. 1996;98(5):944\u2013947.", "ArticleIdList": ["8909490"]}, {"Citation": "Anderson IB, Mullen WH, Meeker JE, Khojasteh Bakht SC, Oishi S, Nelson SD, Blanc PD. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann. Intern. Med. 1996;124(8):726\u2013734.", "ArticleIdList": ["8633832"]}, {"Citation": "Furbee RB, Barlotta KS, Allen MK, Holstege CP. Hepatotoxicity associated with herbal products. Clin. Lab. Med. 2006;26(1):227\u2013241.", "ArticleIdList": ["16567233"]}, {"Citation": "Anderson IB, Mullen WH, Meeker JE, Khojasteh Bakht SC, Oishi S, Nelson SD, Blanc PD. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann. Intern. Med. 1996;124(8):726\u2013734. see comment.", "ArticleIdList": ["8633832"]}, {"Citation": "Khojasteh-Bakht SC, Nelson SD, Atkins WM. Glutathione S-transferase catalyzes the isomerization of (R)-2-hydroxymenthofuran to mintlactones. Arch. Biochem. Biophys. 1999;370(1):59\u201365.", "ArticleIdList": ["10496977"]}, {"Citation": "Thomassen D, Slattery JT, Nelson SD. Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: roles of glutathione. J. Pharmacol. Exp. Ther. 1990;253(2):567\u2013572.", "ArticleIdList": ["2338648"]}, {"Citation": "Gordon WP, Huitric AC, Seth CL, McClanahan RH, Nelson SD. The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran. Drug Metab. Dispos. 1987;15(5):589\u2013594.", "ArticleIdList": ["2891472"]}, {"Citation": "Sztajnkrycer MD, Otten EJ, Bond GR, Lindsell CJ, Goetz RJ. Mitigation of pennyroyal oil hepatotoxicity in the mouse. Acad. Emerg. Med. 2003;10(10):1024\u20131028.", "ArticleIdList": ["14525732"]}, {"Citation": "Madyastha KM, Moorthy B. Pulegone mediated hepatotoxicity: evidence for covalent binding of R(+)-[14C]pulegone to microsomal proteins in vitro. Chem. Biol. Interact. 1989;72(3):325\u2013333.", "ArticleIdList": ["2691105"]}, {"Citation": "McClanahan RH, Thomassen D, Slattery JT, Nelson SD. Metabolic activation of (R)-(+)-pulegone to a reactive enonal that covalently binds to mouse liver proteins. Chem. Res. Toxicol. 1989;2(5):349\u2013355.", "ArticleIdList": ["2519826"]}, {"Citation": "Fabricant DS, Farnsworth NR. Black cohosh (Cimicifuga racemosa) In: Coates PM, editor. Encyclopedia of Dietary Supplements. Dekker, M.; New York: 2005. pp. 41\u201354."}, {"Citation": "Palacio C, Masri G, Mooradian AD. Black cohosh for the management of menopausal symptoms: a systematic review of clinical trials. Drugs Aging. 2009;26(1):23\u201336.", "ArticleIdList": ["19102512"]}, {"Citation": "Farnsworth NR, Mahady GB. Research highlights from the UIC/NIH Center for Botanical Dietary Supplements Research for Women\u2019s Health: Black cohosh from the field to the clinic. Pharm. Biol. 2009;47(8):755\u2013760.", "ArticleIdList": ["PMC2796808", "20161501"]}, {"Citation": "Teschke R. Black cohosh and suspected hepatotoxicity: inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm. A critical review. Menopause. 2010;17(2):426\u2013440.", "ArticleIdList": ["20216279"]}, {"Citation": "Mahady GB, Low Dog T, Barrett ML, Chavez ML, Gardiner P, Ko R, Marles RJ, Pellicore LS, Giancaspro GI, Sarma DN. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause. 2008;15(4 Pt 1):628\u2013638.", "ArticleIdList": ["18340277"]}, {"Citation": "Johnson BM, van Breemen RB. In vitro formation of quinoid metabolites of the dietary supplement Cimicifuga racemosa (black cohosh) Chem. Res. Toxicol. 2003;16(7):838\u2013846.", "ArticleIdList": ["12870886"]}, {"Citation": "Cote CS, Kor C, Cohen J, Auclair K. Composition and biological activity of traditional and commercial kava extracts. Biochem. Biophys. Res. Commun. 2004;322(1):147\u2013152.", "ArticleIdList": ["15313185"]}, {"Citation": "Singh YN, Singh NN. Therapeutic potential of kava in the treatment of anxiety disorders. CNS Drugs. 2002;16(11):731\u2013743.", "ArticleIdList": ["12383029"]}, {"Citation": "Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, Kava Kava. In: The Complete German Commission E Monographs. Blumenthal M, editor. American Botanical Council; Austin, Texas: 1998. pp. 156\u2013157."}, {"Citation": "Johnson BM, Qiu SX, Zhang S, Zhang F, Burdette JE, Yu L, Bolton JL, van Breemen RB. Identification of novel electrophilic metabolites of piper methysticum Forst (Kava) Chem. Res. Toxicol. 2003;16(6):733\u2013740.", "ArticleIdList": ["12807356"]}, {"Citation": "Whitton PA, Lau A, Salisbury A, Whitehouse J, Evans CS. Kava lactones and the kava-kava controversy. Phytochemistry. 2003;64(3):673\u2013679.", "ArticleIdList": ["13679089"]}, {"Citation": "Johnson TE, Kassie F, O\u2019Sullivan MG, Negia M, Hanson TE, Upadhyaya P, Ruvolo PP, Hecht SS, Xing C. Chemopreventive effect of kava on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo[a]pyrene-induced lung tumorigenesis in A/J mice. Cancer Prev. Res. (Phila Pa) 2008;1(6):430\u2013438.", "ArticleIdList": ["PMC9634090", "19138990"]}, {"Citation": "Zanoli P, Zavatti M. Pharmacognostic and pharmacological profile of Humulus lupulus L. J. Ethnopharmacol. 2008;116(3):383\u2013396.", "ArticleIdList": ["18308492"]}, {"Citation": "Overk CR, Yao P, Chadwick LR, Nikolic D, Sun Y, Cuendet MA, Deng Y, Hedayat AS, Pauli GF, Farnsworth NR, van Breemen RB, Bolton JL. Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense) J Agric Food Chem. 2005;53(16):6246\u20136253.", "ArticleIdList": ["PMC1815392", "16076101"]}, {"Citation": "Bowe J, Li XF, Kinsey-Jones J, Heyerick A, Brain S, Milligan S, O\u2019Byrne K. The hop phytoestrogen, 8-prenylnaringenin, reverses the ovariectomy-induced rise in skin temperature in an animal model of menopausal hot flushes. J. Endocrinol. 2006;191(2):399\u2013405.", "ArticleIdList": ["PMC1635969", "17088409"]}, {"Citation": "Bolca S, Possemiers S, Maervoet V, Huybrechts I, Heyerick A, Vervarcke S, Depypere H, De Keukeleire D, Bracke M, De Henauw S, Verstraete W, Van de Wiele T. Microbial and dietary factors associated with the 8-prenylnaringenin producer phenotype: a dietary intervention trial with fifty healthy post-menopausal Caucasian women. Br. J. Nutr. 2007;98(5):950\u2013959.", "ArticleIdList": ["17521469"]}, {"Citation": "Effenberger KE, Johnsen SA, Monroe DG, Spelsberg TC, Westendorf JJ. Regulation of osteoblastic phenotype and gene expression by hop-derived phytoestrogens. J. Steroid Biochem. Mol. Biol. 2005;96(5):387\u2013399.", "ArticleIdList": ["16019205"]}, {"Citation": "Dimpfel W, Suter A. Sleep improving effects of a single dose administration of a valerian/hops fluid extract - a double blind, randomized, placebo-controlled sleep-EEG study in a parallel design using electrohypnograms. Eur. J. Med. Res. 2008;13(5):200\u2013204.", "ArticleIdList": ["18559301"]}, {"Citation": "Heyerick A, Vervarcke S, Depypere H, Bracke M, De Keukeleire D. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas. 2006;54(2):164\u2013175.", "ArticleIdList": ["16321485"]}, {"Citation": "Erkkola R, Vervarcke S, Vansteelandt S, Rompotti P, De Keukeleire D, Heyerick A, randomized A. double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts. Phytomedicine. 2010;17(6):389\u2013396.", "ArticleIdList": ["20167461"]}, {"Citation": "Chadwick LR, Nikolic D, Burdette JE, Overk CR, Bolton JL, van Breemen RB, Froehlich R, Fong HH, Farnsworth NR, Pauli GF. Estrogens and congeners from spent hops (Humulus lupulus L.) J. Nat. Prod. 2004;67:2024\u20132032.", "ArticleIdList": ["PMC7418824", "15620245"]}, {"Citation": "Plazar J, Filipic M, Groothuis GM. Antigenotoxic effect of Xanthohumol in rat liver slices. Toxicol. In Vitro. 2008;22(2):318\u2013327.", "ArticleIdList": ["17981005"]}, {"Citation": "Plazar J, Zegura B, Lah TT, Filipic M. Protective effects of xanthohumol against the genotoxicity of benzo(a)pyrene (BaP), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and tert-butyl hydroperoxide (t-BOOH) in HepG2 human hepatoma cells. Mutat. Res. 2007;632(1-2):1\u20138.", "ArticleIdList": ["17590382"]}, {"Citation": "Lamy V, Roussi S, Chaabi M, Gosse F, Schall N, Lobstein A, Raul F. Chemopreventive effects of lupulone, a hop {beta}-acid, on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis. Carcinogenesis. 2007;28(7):1575\u20131581.", "ArticleIdList": ["17434926"]}, {"Citation": "Dietz BM, Kang YH, Liu G, Eggler AL, Yao P, Chadwick LR, Pauli GF, Farnsworth NR, Mesecar AD, van Breemen RB, Bolton JL. Xanthohumol isolated from Humulus lupulus Inhibits menadione-induced DNA damage through induction of quinone reductase. Chem. Res. Toxicol. 2005;18(8):1296\u20131305.", "ArticleIdList": ["PMC7395304", "16097803"]}, {"Citation": "Liu G, Eggler AL, Dietz BM, Mesecar AD, Bolton JL, Pezzuto JM, van Breeman RB. A screening method for the discovery of potential cancer chemoprevention agents based on mass spectrometric detection of alkylated Keap1. Anal. Chem. 2005;77:6407\u20136414.", "ArticleIdList": ["16194107"]}, {"Citation": "Luo Y, Eggler AL, Liu D, Liu G, Mesecar AD, van Breemen RB. Sites of Alkylation of Human Keap1 by Natural Chemoprevention Agents. J. Am. Soc. Mass Spectrom. 2007", "ArticleIdList": ["PMC2144741", "17980616"]}, {"Citation": "Deng S, Chen SN, Yao P, Nikolic D, van Breemen RB, Bolton JL, Fong HH, Farnsworth NR, Pauli GF. Serotonergic activity-guided phytochemical investigation of the roots of Angelica sinensis. J. Nat. Prod. 2006;69(4):536\u2013541.", "ArticleIdList": ["PMC1866289", "16643021"]}, {"Citation": "Chemical Industry. People\u2019s Republic of China; Beijing: 2000. Pharmacopoeia of the People\u2019s Republic of China-Radix Angelica sinensis."}, {"Citation": "Upton R, Gui Dang. Angelica sinensis. In: Coates P.M.e.a., editor. Encyclopedia of Dietary Supplements. Marcel Dekker; New York: 2005. pp. 159\u2013166."}, {"Citation": "Hou YZ, Zhao GR, Yang J, Yuan YJ, Zhu GG, Hiltunen R. Protective effect of Ligusticum chuanxiong and Angelica sinensis on endothelial cell damage induced by hydrogen peroxide. Life Sci. 2004;75(14):1775\u20131786.", "ArticleIdList": ["15268976"]}, {"Citation": "Hou YZ, Zhao GR, Yuan YJ, Zhu GG, Hiltunen R. Inhibition of rat vascular smooth muscle cell proliferation by extract of Ligusticum chuanxiong and Angelica sinensis. J. Ethnopharmacol. 2005;100(1-2):140\u2013144.", "ArticleIdList": ["15964163"]}, {"Citation": "Kuang X, Yao Y, Du JR, Liu YX, Wang CY, Qian ZM. Neuroprotective role of Z-ligustilide against forebrain ischemic injury in ICR mice. Brain Res. 2006;1102(1):145\u2013153.", "ArticleIdList": ["16806112"]}, {"Citation": "Piersen CE. Phytoestrogens in botanical dietary supplements: implications for cancer. Integr. Cancer Ther. 2003;2(2):120\u2013138.", "ArticleIdList": ["15035899"]}, {"Citation": "Haranaka K, Satomi N, Sakurai A, Haranaka R, Okada N, Kosoto H, Kobayashi M. Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs. J. Tradit. Chin. Med. 1985;5(4):271\u2013278.", "ArticleIdList": ["3834242"]}, {"Citation": "Tsai NM, Lin SZ, Lee CC, Chen SP, Su HC, Chang WL, Harn HJ. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo. Clin. Cancer Res. 2005;11(9):3475\u20133484.", "ArticleIdList": ["15867250"]}, {"Citation": "Tsai NM, Chen YL, Lee CC, Lin PC, Cheng YL, Chang WL, Lin SZ, Harn HJ. The natural compound n-butylidenephthalide derived from Angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo. J. Neurochem. 2006;99(4):1251\u20131262.", "ArticleIdList": ["PMC1804119", "16987298"]}, {"Citation": "Lee WH, Jin JS, Tsai WC, Chen YT, Chang WL, Yao CW, Sheu LF, Chen A. Biological inhibitory effects of the Chinese herb danggui on brain astrocytoma. Pathobiology. 2006;73(3):141\u2013148.", "ArticleIdList": ["17085958"]}, {"Citation": "Cheng YL, Chang WL, Lee SC, Liu YG, Chen CJ, Lin SZ, Tsai NM, Yu DS, Yen CY, Harn HJ. Acetone extract of Angelica sinensis inhibits proliferation of human cancer cells via inducing cell cycle arrest and apoptosis. Life Sci. 2004;75(13):1579\u20131594.", "ArticleIdList": ["15261763"]}, {"Citation": "Yu Y, Du JR, Wang CY, Qian ZM. Protection against hydrogen peroxide-induced injury by Z-ligustilide in PC12 cells. Exp. Brain Res. 2007", "ArticleIdList": ["17717647"]}, {"Citation": "Dietz BM, Liu D, Hagos GK, Yao P, Schinkovitz A, Pro SM, Deng S, Farnsworth NR, Pauli GF, van Breemen RB, Bolton JL. Angelica sinensis and its alkylphthalides induce the detoxification enzyme NAD(P)H: quinone oxidoreductase 1 by alkylating Keap1. Chem. Res. Toxicol. 2008;21(10):1939\u20131948.", "ArticleIdList": ["PMC2615640", "18808158"]}, {"Citation": "Dinkova-Kostova AT, Talalay P. Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol. Nutr. Food Res. 2008;52(Suppl 1):S128\u2013138.", "ArticleIdList": ["18327872"]}, {"Citation": "Food and Drug Administration . Safrole. 1989. PART 189\u2014SUBSTANCES PROHIBITED FROM USE IN HUMAN FOOD, \u00a7 189.180."}, {"Citation": "Food and Drug Administration . Everything Added to Food in the United States (EAFUS): penny royal: In conjunction w/flavors - 172.510. 2010."}, {"Citation": "Food and Drug Administration  FDA Poisonous Plant Database - Toxicity of medicinal herbal preparations. 2008  http://www.accessdata.fda.gov/scripts/Plantox/Detail.CFM?ID=24000."}, {"Citation": "Food and Drug Administration  MedWatch The FDA Safety Information and Adverse Event Reporting Program - Kava (Piper methysticum) 2002  http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154577.htm."}, {"Citation": "Food and Drug Administration . \u00a7 182.20 Essential oils, oleoresins (solvent free) and natural extractives (including distillates) Food and Drug Administration, HHS; 2002. Subpart A - general provisions, 21 CFR Ch. I (4-1-02 Edition) \u00a7 182.20."}, {"Citation": "Eggler AL, Gay KA, Mesecar AD. Molecular mechanisms of natural products in chemoprevention: induction of cytoprotective enzymes by Nrf2. Mol. Nutr. Food Res. 2008;52(Suppl 1):S84\u201394.", "ArticleIdList": ["18435489"]}, {"Citation": "Kwon KH, Barve A, Yu S, Huang MT, Kong AN. Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models. Acta Pharmacol. Sin. 2007;28(9):1409\u20131421.", "ArticleIdList": ["17723174"]}]}], "History": [{"Year": "2010", "Month": "8", "Day": "5"}, {"Year": "2010", "Month": "10", "Day": "5"}, {"Year": "2010", "Month": "10", "Day": "14"}, {"Year": "2010", "Month": "10", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "10", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "8", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2013", "Month": "7", "Day": "9"}], "PublicationStatus": "ppublish", "ArticleIdList": ["20970412", "NIHMS481969", "PMC3706091", "10.1016/j.cbi.2010.10.007", "S0009-2797(10)00586-7"]}}], "PubmedBookArticle": []}